Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. - Gérard L; Michot JM; Burcheri S; Fieschi C; Longuet P; Delcey V; Meignin V; Agbalika F; Chevret S; Oksenhendler E; Galicier L (Blood, 2012)